Targeted Sequencing and Amplicon Sequencing

  • Targeted sequencing and amplicon sequencing are important DNA sequencing approaches used in bioinformatics to investigate selected regions of a genome rather than sequencing the entire genome. These methods focus on specific genes, genomic regions, mutations, or genetic markers associated with a biological question. They are widely applied in medical genetics, cancer research, infectious disease surveillance, microbial genomics, pharmacogenomics, population genetics, agriculture, and molecular biology. By concentrating sequencing resources on selected regions, they can provide high sequencing depth at a lower cost than whole-genome sequencing (WGS) or whole-exome sequencing (WES), particularly when the research question involves a defined set of genomic targets.
  • Targeted sequencing is a broad term describing sequencing strategies designed to analyse selected regions of DNA. The targets may include individual genes, groups of genes, coding exons, promoter regions, disease-associated loci, or specific genomic intervals. The selected regions are enriched before sequencing so that a larger proportion of the sequencing data originates from the regions of interest. Targeted sequencing is useful when researchers already have information about the genes or genomic regions relevant to a disease, trait, organism, or biological process. For example, a clinical gene panel may investigate several genes associated with inherited cardiac disorders, while a cancer panel may examine genes involved in tumour development, treatment response, and drug resistance.
  • Amplicon sequencing is a specific type of targeted sequencing in which selected DNA regions are amplified using polymerase chain reaction (PCR) before sequencing. Primers are designed to bind to sequences flanking the target regions. PCR amplification generates many copies of the selected DNA fragments, which are subsequently prepared for sequencing. The resulting reads are analysed to identify sequence variations, mutations, microbial taxa, or other features within the amplified regions. Amplicon sequencing is particularly useful for analysing relatively small, predefined regions across many samples or for investigating specific marker genes in microbial communities.
  • The main distinction between targeted sequencing and amplicon sequencing is the method used to enrich the regions of interest. Targeted sequencing can use hybridization-based capture, amplicon-based PCR, or other enrichment strategies. Hybridization capture uses probes complementary to selected genomic regions to isolate target fragments from a DNA library. Amplicon sequencing uses PCR primers to amplify the target regions directly. Therefore, amplicon sequencing is one approach within the broader category of targeted sequencing, rather than an entirely separate alternative to it.
  • Hybridization-based target capture generally begins with genomic DNA extraction and fragmentation. Sequencing adapters are added to the DNA fragments to create a sequencing library. Biotin-labelled probes complementary to the selected genomic regions are then introduced. These probes hybridize with matching DNA fragments, and streptavidin-coated magnetic beads are used to capture the biotin-labelled probe–DNA complexes. Unbound fragments are removed through washing, while enriched target fragments are recovered and prepared for sequencing. This approach can capture many genomic regions distributed across different chromosomes and is commonly used in targeted gene panels and other large targeted sequencing projects.
  • Amplicon-based enrichment follows a different procedure. After DNA extraction, primers are used to amplify selected genomic regions through PCR. The amplified products are checked for appropriate size and quantity, purified when necessary, and prepared for sequencing. In some workflows, sequencing adapters and sample-specific indexes are incorporated during amplification. In other workflows, adapters and indexes are added in a separate library preparation step. The precise procedure depends on the sequencing platform and the commercial or laboratory-developed assay.
  • Primer design is one of the most important stages of amplicon sequencing. Primers should bind specifically to the intended target regions and produce fragments of suitable lengths for the selected sequencing platform. Important design considerations include primer melting temperature, GC content, specificity, primer-dimer formation, secondary structures, and the presence of common genetic variants at primer-binding sites. Poor primer design can result in nonspecific amplification, unequal amplification efficiency, or complete amplification failure for particular targets. In multiplex PCR, where many primer pairs are used in a single reaction, primer interactions and differences in amplification efficiency require particular attention.
  • Targeted sequencing can be performed using different sequencing technologies. Short-read platforms, particularly Illumina sequencing systems, are widely used for targeted gene panels and amplicon sequencing because they provide high sequencing accuracy and substantial throughput. Ion Torrent semiconductor sequencing has also been used for targeted sequencing applications. Long-read platforms, including Oxford Nanopore and Pacific Biosciences (PacBio), can be used when longer amplicons, complex genomic regions, haplotype information, or structural variation need to be investigated. The appropriate platform depends on target size, required accuracy, sample number, sequencing depth, and the type of genetic variation being studied.
  • After library preparation, sequencing generates reads representing the enriched target regions. In short-read workflows, raw sequencing data are commonly stored in FASTQ files. Each read contains a nucleotide sequence and corresponding base-quality scores, which indicate the confidence of the base-calling process. FASTQ files may also contain sample identifiers and read information in their headers. In multiplexed experiments, several samples are sequenced together using unique index sequences or barcodes. Demultiplexing separates the reads according to their sample indexes, allowing each sample to be analysed independently. Index misassignment and barcode errors can introduce unwanted cross-sample contamination, so index design and demultiplexing quality should be considered during analysis.
  • Quality control is essential before downstream analysis. Tools such as FastQC, fastp, and MultiQC can be used to examine read quality, sequence length, GC content, adapter contamination, duplication patterns, and other technical characteristics. For amplicon sequencing, additional attention should be given to primer contamination, amplicon length distribution, amplification balance, and the number of reads obtained for each target. Primer sequences may need to be removed before alignment or variant analysis. Tools such as Cutadapt and Trimmomatic can perform adapter and primer trimming, although the trimming settings must be appropriate for the assay design. In some amplicon workflows, primers are removed during specialized processing steps rather than through general-purpose trimming.
  • Following quality control, reads are commonly aligned to a reference genome or reference sequence. Alignment assigns sequencing reads to their corresponding genomic positions and helps identify differences between the sample and the reference. BWA-MEM2 and Bowtie2 are widely used for short-read alignment, while minimap2 supports a range of sequencing data types, including long reads. SAMtools is commonly used to manipulate and inspect SAM, BAM, and CRAM alignment files. Alignment quality is particularly important in targeted sequencing because reads may originate from homologous genes, pseudogenes, repetitive regions, or other sequences with high similarity. Incorrect alignment can produce false variant calls or reduce the accuracy of coverage estimates.
  • Some amplicon sequencing workflows use reference-guided analysis, while others rely on direct comparison of amplified sequences or marker-based classification. For example, microbial community studies often sequence a specific marker gene, such as the bacterial 16S ribosomal RNA gene or fungal internal transcribed spacer (ITS) regions. These reads may be processed using specialized workflows that include quality filtering, primer removal, denoising, chimera detection, and taxonomic classification. In contrast, targeted human gene panels generally align reads to a human reference genome before variant calling and annotation.
  • Coverage and sequencing depth are important measures of targeted sequencing performance. Sequencing depth describes how many reads cover a particular nucleotide position, while coverage breadth describes the proportion of the intended target region covered by at least a specified number of reads. For example, a target region with 500 reads covering each nucleotide has an approximate depth of 500×. However, the average depth across a panel does not necessarily mean that every target has been sequenced equally. Some regions may have very high coverage, while others may have low coverage or no usable reads. Researchers therefore examine both average depth and the percentage of target bases meeting predefined coverage thresholds.
  • A simplified coverage calculation is: Sequencing depth = Total number of aligned bases / Target region length
  • For example, if 5,000,000 aligned bases cover a target region of 10,000 bases, the average sequencing depth is: 5,000,000 / 10,000 = 500×
  • This is an illustrative average. Actual coverage is usually uneven, and the distribution of reads across individual target positions must also be examined. Coverage analysis tools such as mosdepth, SAMtools, BEDTools, and Picard can help calculate depth and identify poorly covered regions. BED files are commonly used to define target intervals, while coverage reports help determine whether the sequencing assay has adequately investigated the intended regions.
  • Variant calling is one of the major applications of targeted sequencing. Once reads have been aligned and assessed, bioinformatics tools identify differences between the sample sequence and the reference genome. These differences may include single-nucleotide variants (SNVs), small insertions and deletions (indels), and, depending on the assay design and analysis method, selected structural variants or copy-number changes. Common small-variant callers include GATK HaplotypeCaller, bcftools, FreeBayes, and DeepVariant. The resulting variants are commonly stored in Variant Call Format (VCF) files or its binary representation, BCF.
  • Variant calling in targeted sequencing requires careful consideration of sequencing depth, mapping quality, base quality, strand balance, allele balance, and the number of supporting reads. A variant supported by only a small number of low-quality reads may represent a sequencing or alignment error. In cancer sequencing, low-frequency variants may be biologically important, but they require sensitive methods and appropriate validation. Unique molecular identifiers (UMIs) can be incorporated during library preparation to distinguish original DNA molecules from PCR duplicates. UMI-based consensus approaches can reduce errors introduced during amplification and sequencing, which is particularly useful for detecting low-frequency variants.
  • After variant calling, variants are annotated to determine their potential biological and clinical significance. Annotation tools such as Ensembl Variant Effect Predictor (VEP), SnpEff, and ANNOVAR can provide information about gene location, transcript consequences, amino acid changes, predicted effects on protein function, and known variant associations. Databases such as ClinVar, gnomAD, dbSNP, and ClinGen provide additional information about clinical interpretations, population frequencies, and gene–disease relationships. However, database annotations and computational predictions do not independently establish whether a variant causes a disease. Interpretation requires consideration of clinical evidence, inheritance patterns, phenotype, population frequency, functional studies, and relevant professional guidelines.
  • Targeted sequencing is widely used in clinical genetics and inherited disease research. Gene panels can investigate multiple genes associated with a particular disorder or group of disorders. For example, a panel may include genes associated with hereditary cancer, cardiomyopathy, epilepsy, hearing loss, or inherited metabolic diseases. Sequencing several relevant genes simultaneously can be more efficient than testing each gene separately. Targeted panels can also help identify pathogenic variants, likely pathogenic variants, and variants of uncertain significance. Nevertheless, a negative result does not exclude a genetic condition because the relevant variant may lie outside the targeted regions or may be difficult to detect using the assay.
  • In cancer research, targeted sequencing is used to identify somatic mutations, copy-number alterations, and other molecular changes associated with tumour development and treatment response. Cancer gene panels may include oncogenes, tumour suppressor genes, DNA repair genes, and genes associated with drug resistance. Tumour samples may contain a mixture of cancer cells, normal cells, stromal cells, and immune cells, which can affect the observed variant allele frequencies. The percentage of tumour cells, sample quality, sequencing depth, and assay sensitivity must therefore be considered when interpreting results. Matched normal samples may help distinguish somatic variants from inherited germline variants.
  • Amplicon sequencing is also widely used in infectious disease research and microbial genomics. Specific genomic regions can be amplified to identify pathogens, detect resistance-associated mutations, or monitor genetic variation during an outbreak. In bacterial identification and microbial ecology, 16S rRNA gene amplicon sequencing is commonly used to investigate bacterial and archaeal community composition. Different variable regions of the 16S rRNA gene, such as V3–V4 or V4, can be amplified using selected primer pairs. Fungal community studies often use internal transcribed spacer regions, while other marker genes are used for particular microbial groups. The choice of marker region and primers affects which organisms can be detected and how accurately they can be classified.
  • Amplicon sequencing of microbial marker genes is commonly analysed using tools such as QIIME 2 and mothur. These workflows can include demultiplexing, quality filtering, denoising, chimera removal, feature-table generation, and taxonomic assignment. DADA2 is widely used to infer amplicon sequence variants (ASVs) by modelling and correcting sequencing errors. Deblur is another method for resolving high-resolution sequence features. Taxonomic classification may use reference databases such as SILVA, the Ribosomal Database Project (RDP), and UNITE for fungal ITS analysis. The resulting data can be used to estimate microbial diversity, compare community composition, and investigate associations between microbial communities and environmental or biological conditions.
  • Amplicon sequencing has important limitations in microbial community analysis. Primer bias can cause some organisms to be amplified more efficiently than others, while mismatches between primers and target sequences can prevent particular organisms from being detected. Different organisms may also have different numbers of copies of the marker gene, meaning that read proportions do not necessarily correspond directly to organism abundance. In addition, marker-gene sequencing usually provides limited information about microbial functional capabilities and may not reliably distinguish closely related species. Shotgun metagenomic sequencing can provide broader information about microbial genomes and functional genes, although it generally requires more sequencing resources and a different analytical workflow.
  • Targeted sequencing is also used in pharmacogenomics to investigate genetic variants that influence drug metabolism, drug transport, and treatment response. Selected genes, including genes encoding drug-metabolizing enzymes and transport proteins, can be analysed to identify variants relevant to medication selection or dosage. Targeted panels are also applied in population genetics, animal and plant breeding, conservation genetics, and agricultural research. Researchers may investigate genes associated with disease resistance, productivity, adaptation, or specific inherited traits. The usefulness of these results depends on the quality of the reference data, the genetic diversity of the studied population, and the strength of evidence connecting the detected variants with the biological trait.
  • Amplicon sequencing is particularly useful for studies requiring high-depth analysis of a limited number of genomic regions. It can be applied to mutation screening, microbial marker analysis, validation of variants identified by WGS or WES, gene expression studies when combined with appropriate targeted cDNA amplification, and monitoring of known mutations. However, PCR-based enrichment can introduce amplification bias, allele dropout, polymerase errors, and chimeric products. Allele dropout occurs when one allele is not amplified effectively, potentially causing a heterozygous variant to appear homozygous or to be missed. This is especially important when a variant occurs within a primer-binding site.
  • Targeted sequencing and amplicon sequencing should be distinguished from whole-genome and whole-exome sequencing. WGS investigates genomic regions across the genome, while WES focuses mainly on coding regions selected through exome enrichment. Targeted sequencing examines a predefined set of genes or genomic intervals, and amplicon sequencing amplifies specific regions using PCR. Targeted panels generally provide deeper coverage of selected regions than broad genome-wide approaches when sequencing resources are concentrated on those targets. However, they cannot provide comprehensive information about regions that were not included in the assay.
  • The choice between hybridization capture and amplicon sequencing depends on the research objectives and technical requirements. Hybridization capture is often suitable for panels containing many targets, targets distributed across large genomic regions, and assays requiring flexibility in the selection of target intervals. It can be more tolerant of variation at individual primer-binding sites because it does not depend on a separate PCR primer pair for every target, although capture probes can also be affected by sequence variation and hybridization conditions. Amplicon sequencing is often suitable for smaller, predefined targets, rapid screening, and high-throughput analysis of many samples. It can provide efficient enrichment but is more dependent on primer design and amplification performance. Neither approach is universally superior; assay performance must be evaluated for the intended application.
  • Several quality metrics are important when evaluating targeted sequencing experiments. These include total read count, percentage of reads assigned to the correct sample, on-target rate, mean and median target depth, coverage uniformity, percentage of target bases above specified depth thresholds, mapping quality, duplicate rate, and the proportion of reads passing quality filters. For amplicon sequencing, additional metrics include the number of reads per amplicon, amplification balance, primer-specific performance, and the proportion of reads assigned to expected target sequences. For microbial marker-gene studies, chimera frequency, denoising results, taxonomic assignment rates, and the number of retained ASVs are also important.
  • The bioinformatics workflow should be designed around the sequencing assay. A typical targeted DNA sequencing workflow includes sample identification, FASTQ quality control, adapter and primer trimming, alignment to a reference genome, duplicate handling, coverage assessment, variant calling, variant filtering, annotation, and reporting. A typical amplicon marker-gene workflow includes demultiplexing, primer removal, quality filtering, denoising, chimera detection, feature-table construction, taxonomic classification, and diversity analysis. These workflows share some data-processing steps but differ in their assumptions and biological objectives. Applying a general genomic variant-calling workflow to microbial marker-gene data, for example, may not be appropriate.
  • Reproducible analysis requires recording the reference genome or marker database, its version, the target-region definitions, primer sequences, sequencing platform, library preparation method, software versions, and analysis parameters. Researchers should preserve the original FASTQ files, sample metadata, quality-control reports, alignment files where appropriate, variant files, and analysis scripts. Workflow managers such as Snakemake and Nextflow can help organize complex analyses and make them repeatable. Container technologies such as Docker and Apptainer can preserve software environments, while version control systems such as Git can track changes to scripts and analytical configurations. For clinical applications, laboratories should also follow relevant validation, quality-management, and reporting requirements.
  • Targeted sequencing and amplicon sequencing have several limitations that must be considered when interpreting results. Both approaches are restricted to the regions selected during assay design and may miss variants outside those regions. Uneven coverage can leave some targets inadequately investigated. PCR-based methods may introduce amplification bias and allele dropout, while hybridization capture can show variable enrichment efficiency and off-target capture. Short-read sequencing may have difficulty resolving repetitive regions, highly homologous genes, complex structural variants, and some regions with extreme GC content. Low-frequency variants may be difficult to detect without sufficient sequencing depth and an appropriately validated error-control strategy. Furthermore, findings from targeted assays should not be interpreted as evidence that untested genomic regions are free of variation.
  • In conclusion, targeted sequencing and amplicon sequencing are valuable approaches for investigating selected genomic regions with high sequencing depth and focused analytical objectives. Targeted sequencing includes several enrichment strategies, particularly hybridization capture and PCR-based amplification, while amplicon sequencing specifically relies on PCR to enrich the regions of interest. These methods support applications in inherited disease analysis, cancer genomics, infectious disease research, microbial ecology, pharmacogenomics, agriculture, and population genetics. Their effectiveness depends on careful target selection, assay design, sequencing quality, appropriate bioinformatics tools, and accurate interpretation. Understanding their principles, differences, advantages, and limitations enables researchers to select suitable sequencing strategies and generate reliable biological information.
Author:

Leave a Reply

Your email address will not be published. Required fields are marked *